<DOC>
	<DOCNO>NCT00197093</DOCNO>
	<brief_summary>This study placebo-controlled study ass safety tolerability novel antipsychotic medication , ( 773812 ) give schizophrenic patient twenty-eight day . Assessments include blood sample determine drug concentration , psychiatric assessment treatment , movement assessment evaluate potential side effect .</brief_summary>
	<brief_title>In-Patient Study In Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Must schizophrenia stable least three month . Willing discontinue current antipsychotic medication ( supervision ) prior study . Willing live study center total 38 day return three followup visit . Taking medication condition schizophrenia . History alcohol drug abuse within six month study , alcohol consumption must meet moderate guideline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>